Testing effectiveness (Phase 2)Study completedNCT00070447
What this trial is testing
Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Who this might be right for
Lymphoma
National Cancer Institute (NCI)